CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Utah Medical Products, Inc. - UTMD CFD

    68.40
    2.14%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.24
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Utah Medical Products Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 66.97
    Open* 66.87
    1-Year Change* -29.57%
    Day's Range* 66.87 - 68.4
    52 wk Range 75.00-100.59
    Average Volume (10 days) 12.53K
    Average Volume (3 months) 231.16K
    Market Cap 292.90M
    P/E Ratio 17.35
    Shares Outstanding 3.63M
    Revenue 51.47M
    EPS 4.65
    Dividend (Yield %) 1.48699
    Beta 0.15
    Next Earnings Date Jan 29, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 19, 2024 68.40 1.55 2.32% 66.85 68.62 66.85
    Apr 18, 2024 66.97 -0.08 -0.12% 67.05 67.36 66.85
    Apr 17, 2024 67.57 -0.52 -0.76% 68.09 68.51 67.20
    Apr 16, 2024 67.97 0.02 0.03% 67.95 68.56 67.46
    Apr 15, 2024 68.29 -0.34 -0.50% 68.63 69.00 68.09
    Apr 12, 2024 68.61 -0.22 -0.32% 68.83 69.30 68.42
    Apr 11, 2024 70.11 0.16 0.23% 69.95 71.11 69.58
    Apr 10, 2024 69.83 -0.12 -0.17% 69.95 70.79 68.88
    Apr 9, 2024 70.94 1.79 2.59% 69.15 71.24 69.15
    Apr 8, 2024 69.95 0.91 1.32% 69.04 70.02 68.97
    Apr 5, 2024 69.01 0.92 1.35% 68.09 69.15 68.09
    Apr 4, 2024 68.20 -0.40 -0.58% 68.60 69.08 68.09
    Apr 3, 2024 68.60 -0.03 -0.04% 68.63 69.97 68.45
    Apr 2, 2024 69.32 -0.63 -0.90% 69.95 70.52 68.63
    Apr 1, 2024 70.55 1.62 2.35% 68.93 70.68 68.57
    Mar 28, 2024 70.94 2.85 4.19% 68.09 71.21 68.09
    Mar 27, 2024 69.75 1.66 2.44% 68.09 70.07 68.09
    Mar 26, 2024 67.96 -0.66 -0.96% 68.62 69.25 67.89
    Mar 25, 2024 69.26 0.71 1.04% 68.55 70.17 68.51
    Mar 22, 2024 68.41 0.31 0.46% 68.10 69.28 67.95

    Utah Medical Products, Inc. Events

    Time (UTC) Country Event
    Tuesday, April 23, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q1 2024 Utah Medical Products Inc Earnings Release
    Q1 2024 Utah Medical Products Inc Earnings Release

    Forecast

    -

    Previous

    -
    Friday, May 3, 2024

    Time (UTC)

    18:00

    Country

    US

    Event

    Utah Medical Products Inc Annual Shareholders Meeting
    Utah Medical Products Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -

    Time (UTC)

    18:00

    Country

    US

    Event

    Utah Medical Products Inc Annual Shareholders Meeting
    Utah Medical Products Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Tuesday, July 23, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q2 2024 Utah Medical Products Inc Earnings Release
    Q2 2024 Utah Medical Products Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 52.281 49.054 42.178 46.904 41.998
    Revenue 52.281 49.054 42.178 46.904 41.998
    Cost of Revenue, Total 20.085 18.137 16.63 17.438 15.692
    Gross Profit 32.196 30.917 25.548 29.466 26.306
    Total Operating Expense 32.491 30.174 28.47 29.272 23.301
    Selling/General/Admin. Expenses, Total 4.857 4.879 11.354 11.351 7.155
    Research & Development 0.493 0.526 0.486 0.483 0.454
    Operating Income 19.79 18.88 13.708 17.632 18.697
    Interest Income (Expense), Net Non-Operating 0.661 0.166 0.112 0.254 0.249
    Other, Net 0.208 0.015 0.02 -0.002 0.513
    Net Income Before Taxes 20.659 19.061 13.84 17.884 19.459
    Net Income After Taxes 16.473 14.788 11.061 14.461 15.325
    Net Income Before Extra. Items 16.473 14.788 11.061 14.461 15.325
    Net Income 16.473 14.788 10.798 14.727 18.555
    Income Available to Common Excl. Extra. Items 16.473 14.788 11.061 14.461 15.325
    Income Available to Common Incl. Extra. Items 16.473 14.788 10.798 14.727 18.555
    Diluted Net Income 16.473 14.788 10.798 14.727 18.555
    Diluted Weighted Average Shares 3.643 3.66 3.672 3.739 3.748
    Diluted EPS Excluding Extraordinary Items 4.52182 4.04044 3.01225 3.86761 4.08885
    Dividends per Share - Common Stock Primary Issue 1.17 1.145 1.125 1.105 1.085
    Diluted Normalized EPS 4.66847 4.0451 3.01225 3.86761 4.08885
    Total Extraordinary Items -0.263 0.266 3.23
    Depreciation / Amortization 6.386 6.61
    Unusual Expense (Income) 0.67 0.022
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 12.866 12.52 13.574 12.955 13.428
    Revenue 12.866 12.52 13.574 12.955 13.428
    Cost of Revenue, Total 5.127 4.677 5.247 4.769 5.277
    Gross Profit 7.739 7.843 8.327 8.186 8.151
    Total Operating Expense 8.441 8.081 8.504 7.814 8.371
    Selling/General/Admin. Expenses, Total 3.181 3.26 3.134 2.933 2.959
    Research & Development 0.133 0.144 0.123 0.112 0.135
    Operating Income 4.425 4.439 5.07 5.141 5.057
    Other, Net 0.747 0.68 -0.14 0.198 0.142
    Net Income Before Taxes 5.172 5.119 5.591 5.339 5.199
    Net Income After Taxes 4.2 4.214 4.555 4.28 4.103
    Net Income Before Extra. Items 4.2 4.214 4.555 4.28 4.103
    Net Income 4.2 4.214 4.555 4.28 4.103
    Income Available to Common Excl. Extra. Items 4.2 4.214 4.555 4.28 4.103
    Income Available to Common Incl. Extra. Items 4.2 4.214 4.555 4.28 4.103
    Diluted Net Income 4.2 4.214 4.555 4.28 4.103
    Diluted Weighted Average Shares 3.639 3.636 3.625 3.634 3.65
    Diluted EPS Excluding Extraordinary Items 1.15416 1.15897 1.25655 1.17777 1.12411
    Dividends per Share - Common Stock Primary Issue 0.295 0.295 0.295 0.295 0.29
    Diluted Normalized EPS 1.15416 1.15897 1.25655 1.17777 1.12411
    Interest Income (Expense), Net Non-Operating 0.661
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 89.919 73.158 62.262 54.886 60.903
    Cash and Short Term Investments 75.052 60.974 51.59 42.787 51.112
    Cash
    Short Term Investments 0
    Total Receivables, Net 5.538 5.132 4.104 4.742 3.956
    Accounts Receivable - Trade, Net 5.538 5.132 4.09 4.699 3.943
    Total Inventory 8.814 6.596 6.222 6.913 5.412
    Prepaid Expenses 0.515 0.456 0.346 0.444 0.423
    Total Assets 123.874 115.636 111.745 109.787 99.768
    Property/Plant/Equipment, Total - Net 10.224 11.067 11.326 10.728 10.359
    Property/Plant/Equipment, Total - Gross 33.168 33.869 33.91 32.598 31.549
    Accumulated Depreciation, Total -22.944 -22.802 -22.584 -21.87 -21.19
    Goodwill, Net 13.354 14.098 14.164 13.961 13.703
    Intangibles, Net 10.377 17.313 23.993 30.212 14.803
    Total Current Liabilities 5.96 3.745 3.791 3.448 5.26
    Accounts Payable 1.218 0.761 0.788 1.098 0.975
    Accrued Expenses 4.405 2.948 3 2.35 3.44
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.337 0.036 0.003 0.845
    Total Liabilities 9.62 8.498 8.923 8.694 10.776
    Total Long Term Debt 0 0 0 0 0
    Deferred Income Tax 2.063 2.682 2.802 2.76 3.075
    Total Equity 114.254 107.138 102.822 101.093 88.992
    Preferred Stock - Non Redeemable, Net 0 0
    Common Stock 0.036 0.037 0.036 0.037 0.037
    Additional Paid-In Capital 0.251 0.841 0.115 0.018 0.122
    Retained Earnings (Accumulated Deficit) 126.006 115.314 110.952 110.82 100.123
    Other Equity, Total -12.039 -9.054 -8.281 -9.782 -11.29
    Total Liabilities & Shareholders’ Equity 123.874 115.636 111.745 109.787 99.768
    Total Common Shares Outstanding 3.628 3.655 3.643 3.722 3.72
    Other Liabilities, Total 1.597 2.071 2.33 2.486 2.441
    Cash & Equivalents 75.052 60.974 51.59 42.787 51.112
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 101.847 98.807 95.112 89.919 84.242
    Cash and Short Term Investments 88.209 84.619 80.912 75.052 69.511
    Cash & Equivalents 88.209 84.619 80.912 75.052 69.511
    Total Receivables, Net 3.487 3.604 3.818 5.538 6.034
    Accounts Receivable - Trade, Net 3.487 3.604 3.818 5.538 6.034
    Total Inventory 9.709 10.117 9.94 8.814 8.31
    Other Current Assets, Total 0.387
    Total Assets 131.243 130.475 127.77 123.874 118.413
    Property/Plant/Equipment, Total - Net 10.346 10.541 10.241 10.224 10.258
    Goodwill, Net 13.424 13.676 13.502 13.354 12.871
    Intangibles, Net 5.626 7.451 8.915 10.377 11.042
    Total Current Liabilities 4.177 5.144 6.074 5.96 6.269
    Accounts Payable 0.511 1.336 1.028 1.218 1.289
    Accrued Expenses 3.666 3.808 5.046 4.742 4.98
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 7.541 8.714 9.752 9.62 10.227
    Total Long Term Debt 0 0 0 0 0
    Deferred Income Tax 1.803 1.998 2.094 2.063 1.929
    Other Liabilities, Total 1.561 1.572 1.584 1.597 2.029
    Total Equity 123.702 121.761 118.018 114.254 108.186
    Common Stock 0.036 0.036 0.036 0.036 0.036
    Additional Paid-In Capital 0.521 0.432 0.322 0.251 0.058
    Retained Earnings (Accumulated Deficit) 135.144 132.279 129.15 126.006 122.522
    Other Equity, Total -11.999 -10.986 -11.49 -12.039 -14.43
    Total Liabilities & Shareholders’ Equity 131.243 130.475 127.77 123.874 118.413
    Total Common Shares Outstanding 3.629 3.629 3.628 3.628 3.625
    Prepaid Expenses 0.442 0.467 0.442 0.515
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 16.473 14.788 10.798 14.727 18.555
    Cash From Operating Activities 21.147 21.203 20.137 17.056 16.834
    Cash From Operating Activities 0.612 0.636 0.655 0.7 0.765
    Amortization 6.417 6.645 6.515 6.144 2.191
    Deferred Taxes -0.401 -0.092 -0.026 -0.396 -0.326
    Non-Cash Items 0.272 0.232 0.202 0.204 -0.309
    Cash Taxes Paid 4.97 4.617 3.186 5.304 4.851
    Cash Interest Paid 0 0 0 0
    Changes in Working Capital -2.226 -1.006 1.993 -4.323 -4.042
    Cash From Investing Activities -0.818 -0.552 -0.86 -21.54 0.534
    Capital Expenditures -0.818 -0.552 -0.86 -21.54 -0.402
    Cash From Financing Activities -5.484 -10.905 -10.734 -4.227 -4.777
    Financing Cash Flow Items 0
    Total Cash Dividends Paid -3.163 -11.465 -4.116 -4.112 -4.026
    Issuance (Retirement) of Stock, Net -2.321 0.56 -6.618 -0.115 -0.751
    Foreign Exchange Effects -0.767 -0.362 0.26 0.386 -1.354
    Net Change in Cash 14.078 9.384 8.803 -8.325 11.237
    Issuance (Retirement) of Debt, Net
    Other Investing Cash Flow Items, Total 0 0.936
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 4.214 16.473 11.918 7.638 3.534
    Cash From Operating Activities 6.915 21.147 15.467 9.878 5.046
    Cash From Operating Activities 0.155 0.612 0.454 0.302 0.149
    Amortization 1.596 6.417 4.837 3.257 1.646
    Deferred Taxes -0.003 -0.401 -0.409 -0.286 -0.144
    Non-Cash Items 0.066 0.272 0.181 0.135 0.065
    Cash Taxes Paid 0.129 4.97 3.502 2.467 0.082
    Cash Interest Paid 0
    Changes in Working Capital 0.887 -2.226 -1.514 -1.168 -0.204
    Cash From Investing Activities -0.043 -0.818 -0.78 -0.459 -0.237
    Capital Expenditures -0.043 -0.818 -0.78 -0.459 -0.237
    Cash From Financing Activities -1.049 -5.484 -4.564 -3.532 0.019
    Total Cash Dividends Paid -1.07 -3.163 -2.112 -1.06 0
    Issuance (Retirement) of Stock, Net 0.021 -2.321 -2.452 -2.472 0.019
    Foreign Exchange Effects 0.037 -0.767 -1.586 -0.637 0.071
    Net Change in Cash 5.86 14.078 8.537 5.25 4.899

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Utah Medical Products, Inc. Company profile

    About Utah Medical Products, Inc.

    Utah Medical Products, Inc. (UTMD) manufactures and markets a range of specialty medical devices. Its product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME and OptiMicro electrosurgical devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. Its medical devices are sold directly to clinical end-user facilities or a designated stocking distributor for a medical facility. In addition, some of its devices are sold through distributors and national hospital distribution companies.

    Financial summary

    BRIEF: For the nine months ended 30 September 2021, Utah Medical Products, Inc. revenues increased 20% to $36.1M. Net income increased 44% to $10.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other income increase of 2% to $129K (income). Dividend per share increased from $0.84 to $0.86.

    Equity composition

    Common Stock $.01 Par, 3/11, 50M auth., 3,620,000 issd. Insiders own 11.09%. PO 11/82, 1.75M shares @ $1 by Matthew R.White Investment Co. 3/93, 3-for-2 stock split. *During FY'94, UM repurchased & retired 1,134,800 shares.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    7043 S 300 West
    MIDVALE
    UTAH 84047
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    US100

    17,037.80 Price
    -1.980% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 7.0

    XRP/USD

    0.52 Price
    +2.570% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    BTC/USD

    64,050.25 Price
    -0.170% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    Gold

    2,392.09 Price
    +0.540% 1D Chg, %
    Long position overnight fee -0.0192%
    Short position overnight fee 0.0110%
    Overnight fee time 21:00 (UTC)
    Spread 0.40

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading